NHS launches spring COVID-19 booster campaign
An estimated 7.5 million people will be invited to receive the booster
Read More
Tag: vaccines
Europe contributes over €750m to African Vaccines Manufacturing Accelerator
The initiative aims to improve African pandemics, outbreaks, preparedness and responses
Read More
Moderna opts for Oxfordshire in quest for innovation
Vaccines developed at the facility will cover a wide range of respiratory diseases
Read More
Vicebio targets development of novel vaccines
Molecular clamp technology is a protein tag that stabilises a wide range of complex viral proteins
Read More
Sanofi plans €400m annual investment in mRNA vaccines ‘centre of excellence’
Sanofi is currently collaborating with Translate Bio on a mRNA-based COVID-19 vaccine candidate
Read More
‘New’ GSK spotlights growth potential of vaccines and speciality medicines
British drugmaker predicted a substantial £33bn sales ambition by 2031 in investor update
Read More
US supports waiving IP for COVID vaccines
MSF has applauded the move, but the IFPMA said the decision is “disappointing”
Read More
Gov unveils plans to boost UK’s vaccines manufacturing capabilities
New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100 million investment
Read More
Gov signs deals with BioNTech/Pfizer and Valneva for COVID vaccines
The UK has now secured early access to three different types of promising COVID-19 vaccine candidates
Read More
GSK links with Medicago to develop novel COVID-19 vaccine
Phase I clinical testing scheduled to begin mid-July
Read More
New consortium will monitor safety/efficacy of COVID-19 vaccines
The move provides the opportunity to conduct essential post-marketing surveillance
Read More
Oxford Biomedica and VMIC announce collaboration
The five-year deal will see the parties work collaboratively to facilitate the manufacture of viral vector based vaccines
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
